Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Emcure Pharma IPO and Ethos Limited IPO.
Emcure Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Ethos Limited IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
| Emcure Pharma IPO | Ethos Limited IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | IPO | IPO |
| Process Type | Book Built Issue | Book Built Issue |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Kotak Mahindra Capital Company Limited Axis Capital Limited Jefferies India Private Limited J.P. Morgan India Private Limited |
Emkay Global Financial Services Ltd Incred Capital Financial Services Pvt Ltd |
| Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
|
| Anchor Investor | Anchor Investor |
|
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Emcure Pharma IPO is whereas the issue size of the Ethos Limited IPO is up to ₹472.29 Cr. The final issue price of Emcure Pharma IPO is and of Ethos Limited IPO is ₹878.00 per share.
| Emcure Pharma IPO | Ethos Limited IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹836.00 per share | |
| Issue Price (Upper) | ₹878.00 per share | |
| Issue Price (Final) | ₹878.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 17 shares | |
| Fresh Issue Size | 42,71,071 shares | |
| Fresh Issue Size (Amount) | up to ₹800.00 Cr | up to ₹375.00 Cr |
| OFS Issue Size | 1,36,78,839 shares | 11,08,037 shares |
| OFS Issue Size (Amount) | up to ₹97.29 Cr | |
| Issue Size Total | 53,79,108 shares | |
| Issue Size Total (Amount) | up to ₹472.29 Cr |
Emcure Pharma IPO opens on , while Ethos Limited IPO opens on May 18, 2022. The closing date of Emcure Pharma IPO and Ethos Limited IPO is , and May 20, 2022, respectively.
| Emcure Pharma IPO | Ethos Limited IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | May 18, 2022 | |
| Issue Close | May 20, 2022 | |
| Basis Of Allotment (Tentative) | May 25, 2022 | |
| Initiation of Refunds (Tentative) | May 26, 2022 | |
| Credit of Share (Tentative) | May 27, 2022 | |
| Listing date (Tentative) | May 30, 2022 | |
| Anchor Lockin End date 1 | Jun 24, 2022 | |
| Anchor Lockin End date 2 | Aug 23, 2022 |
Emcure Pharma IPO P/E ratio is , as compared to Ethos Limited IPO P/E ratio of 96.
| Emcure Pharma IPO | Ethos Limited IPO | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 81.01% | |||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 61.65% | |||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 96 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹2050.06 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||
In the Emcure Pharma IPO retail investors (RII) are offered while in Ethos Limited IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Emcure Pharma IPO and 11,83,115 shares in Ethos Limited IPO.
| Emcure Pharma IPO | Ethos Limited IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | 11,83,115 shares | |
| NII | 8,39,053 shares | |
| RII | 19,57,789 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 39,79,957 shares |
Emcure Pharma IPO subscribed in total, whereas Ethos Limited IPO subscribed 1.04x.
| Emcure Pharma IPO | Ethos Limited IPO | |
|---|---|---|
| QIB (times) | 1.06x | |
| NII (times) | 1.48x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.84x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.04x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
